MRS1191

For research use only. Not for therapeutic Use.

  • CAT Number: I008162
  • CAS Number: 185222-90-6
  • Molecular Formula: C31H27NO4
  • Molecular Weight: 477.56
  • Purity: ≥95%
Inquiry Now

MRS1191 (CAT: I008162) is a selective A3 adenosine receptor antagonist. Adenosine receptors are a class of G protein-coupled receptors that are involved in various physiological processes. MRS1191 specifically targets and blocks the A3 adenosine receptor subtype, preventing the binding of adenosine and inhibiting its downstream signaling pathways. By selectively antagonizing the A3 adenosine receptor, MRS1191 can modulate the activity of adenosine, potentially leading to therapeutic effects in conditions where A3 receptor activation is involved. Its selectivity for the A3 receptor makes it a valuable tool for studying the role of this receptor subtype and exploring its potential as a target for drug development.


Catalog Number I008162
CAS Number 185222-90-6
Synonyms

MRS1191; MRS 1191; MRS-1191.;O3-ethyl O5-(phenylmethyl) 2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate

Molecular Formula C31H27NO4
Purity ≥95%
Target Adenosine Receptor
Solubility Soluble in DMSO
Storage 0 - 4 °C for short term, or -20 °C for long term
IUPAC Name 5-O-benzyl 3-O-ethyl 2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
InChI InChI=1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3
InChIKey SNVFDPHQAOXWJZ-UHFFFAOYSA-N
SMILES CCOC(=O)C1=C(NC(=C(C1C#CC2=CC=CC=C2)C(=O)OCC3=CC=CC=C3)C4=CC=CC=C4)C
Reference

1: Inoue Y, Tanaka H, Sumi Y, Woehrle T, Chen Y, Hirsh MI, Junger WG. A3
adenosine receptor inhibition improves the efficacy of hypertonic saline
resuscitation. Shock. 2011 Feb;35(2):178-83. doi: 10.1097/SHK.0b013e3181f221fb.
PubMed PMID: 20661181; PubMed Central PMCID: PMC3038630.
</br>

2: Das S, Tosaki A, Bagchi D, Maulik N, Das DK. Resveratrol-mediated activation
of cAMP response element-binding protein through adenosine A3 receptor by
Akt-dependent and -independent pathways. J Pharmacol Exp Ther. 2005
Aug;314(2):762-9. Epub 2005 May 5. PubMed PMID: 15879002.

</br>
3: Rivo J, Zeira E, Galun E, Matot I. Activation of A3 adenosine receptors
attenuates lung injury after in vivo reperfusion. Anesthesiology. 2004
Nov;101(5):1153-9. PubMed PMID: 15505451.

Request a Quote